Aryl-substituted alicylic compound and medical composition comprising the same
AssigneeDainippon Pharmaceutical Co., Ltd.
InventorsToshiya Morie, Seiji Iwama, Mitsue Notake, Tomoko Kitano
Life of this patent
Estimating the term…
Loading patent…
AssigneeDainippon Pharmaceutical Co., Ltd.
InventorsToshiya Morie, Seiji Iwama, Mitsue Notake, Tomoko Kitano
Estimating the term…
An aryl-substituted alicyclic compound of the formula (I): 1 wherein U is 1,4,5,6-tetrahydropyrimidin-2-yl, etc., A is phenylene, etc., B is piperidine-1,4-diyl, etc., Z is —CONH—, etc., R3 is hydrogen, etc., R5 is hydrogen, aryl, etc., R6 is a mono-substituted amino (e,g., benzyloxycarbonylamino), R7 is hydrogen, etc., and a process for preparation thereof, and a pharmaceutical composition containing the same. The compound of the present invention has a high selectivity for αvβ3 integrin, and exhibits a potent inhibitory activity thereto, and hence, it is useful as a preventive or/and a therapeutic agent for a disease in which αvβ3 integrin is involved.
An aryl-substituted alicyclic compound of the following formula (I), a prodrug thereof, a pharmaceutically acceptable salt thereof or an N-oxide derivative thereof, or a hydrate or solvate thereof.
An aryl-substituted alicyclic compound of the following formula (Ia), a prodrug thereof, a pharmaceutically acceptable salt thereof or an N-oxide derivative thereof, or a hydrate or solvate thereof.
An aryl-substituted alicyclic compound of the following formula (Ib), a prodrug thereof, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof.
An aryl-substituted alicyclic compound, which is selected from (2S)-2-benzyloxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl) aminophenyl]piperidin-4-yl] carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[2-(1,4,5,6-tetrahydropyrimidin-2-yl) amino-6-methylpyrimidin-4-yl] piperidin-4-yl] carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-5-[4-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[4-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]carbonylamino]propanoic acid, (2S)-2-isopropoxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[3-(1H-4,5,6,7-tetrahydro-1,3-diazepin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarboriylamino-5-[4-[2-methoxy-5-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[2-methoxy-5-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-isobutoxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-hexyloxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)aminopyridin-2-yl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[11-[3-(4-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[3-(4,4-dimethyl-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[3-(4-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[4-methyl-3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-(N′-hexylureido)-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-(2-methoxyethoxycarbonylamino)-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-butoxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-octyloxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-neopentyloxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[4-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]cyclohexane]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[5-fluoro-3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-hexyloxycarbonylamino-5-[4-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[3-(2-imidazolin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[4-(4-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminopyridin-2-yl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[11-[3-(4,4-difluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-isobutoxycarbonylamino-5-[4-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-isobutoxycarbonylamino-3-[[1-[3-(5,5-dimethyl-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-isobutoxycarbonylamino-3-[[1-[3-(5-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-isobutoxycarbonylamino-3-[[1-[3-(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-ethoxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-decyloxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-allyloxycarbonylamino-3-[[1-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-benzyloxycarbonylamino-5-[4-[3-(5-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-isobutoxycarbonylamino-5-[4-[3-(5-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-hexyloxycarbonylamino-5-[4-[3-(5-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, and (2S)-2-benzyloxycarbonylamino-5-[4-[2-fluoro-5-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, or a prodrug thereof, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof.
An aryl-substituted alicyclic compound, which is selected from (2S)-2-isopropoxycarbonylamino-3-[[4-[3-(2-oxazolidin-2-yl)aminophenyl]piperazin-1-yl]carbonylamino]propanoic acid, (2S)-2-isobutoxycarbonylamino-3-[[4-[3-(7H-3,4,5,6-tetrahydroazepin-2-yl)aminophenyl]piperazin-1-yl]carbonylamino]propanoic acid, (2S)-3-[[1-[2-(benzylaminocarbonyl)amino-6-methylpyrimidin-4-yl]piperidin-4-yl]-carbonylamino]-2-(benzyloxycarbonylamino)propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[N-[8-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]-8-azabicyclo[3.2.1]octan-3-yl] carbamoyl]propanoic acid, (2S)-2-ethoxycarbonylamino-3-[[8-[3-(5,5-difluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]-8-azabicyclo[3.2.1]octan-3-yl]carbonylamino]propanoic acid, (2S)-3-[[1-[5-fluoro-3-(1H-4,5,6,7-tetrahydro-1,3-diazepin-2-yl)aminophenyl]piperidin-4-yl]carbonylamino]-2-(isobutoxycarbonylamino)propanoic acid, (2S)-2-isopropoxycarbonylamino-5-[4-[5-(1H-4,5,6,7-tetrahydro-1,3-diazepin-2-yl)amino-2-methoxyphenyl]-piperazin-1-yl]-5-oxopentanoic acid, (2S)-5-[4-[2-fluoro-5-(1H-4,5,6,7-tetrahydro-1,3-diazepin-2-yl)amino]piperazin-1-yl]-2-(isobutoxycarbonylamino)-5-oxopentanoic acid, (2S)-2-butoxycarbonylamino-5-[4-[4-(1H-4,5,6,7-tetrahydro-1,3-diazepin-2-yl)aminopyridin-2-yl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[1-[4-(1H-4,5,6,7-tetrahydro-1,3-diazepin-2-yl)aminopyridin-2-yl]piperidin-4-yl]carbonylamino]propanoic acid, (2S)-2-hexyloxycarbonylamino-3-[[1-[4-(2-imidazolin-2-yl)aminopyridin-2-yl]piperidin-4-yl]carbonylamino]-propanoic acid, (2S)-2-isopropoxycarbonylamino-3-[[4-[4-(2-imidazolin-2-yl)aminopyridin-2-yl]piperazin-1-yl]carbonylamino]propanoic acid, (2S)-2-benzyloxycarbonylamino-3-[[2,6-dimethyl-4-[3-(1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]carbonylamino]-propanoic acid, (2S)-2-hexyloxycarbonylamino-3-[[2,5-dimethyl-4-[3-(5-fluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]carbonylamino]propanoic acid, (2S)-2-isobutoxycarbonylamino-5-[2,6-dimethyl-4-[3-(5,5-dimethyl-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-benzyloxycarbonylamino-5-[3,5-dimethyl-4-[3-(5,5-difluoro-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]-5-oxopentanoic acid, (2S)-2-hexyloxycarbonylamino-3-[[3,5-dimethyl-4-[3-(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)aminophenyl]piperazin-1-yl]carbonylamino]-
Dependencies are inferred from the claim text.